BioMed Central

Feed Category: 

Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014–2018

The epidemiology of dialysis patients has been little studied in developing countries and economies in transition. We examined the prevalence, incidence and mortality rate of dialysis patients in Kazakhstan, v...

Feed Item Url: 
https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-02047-6

Identification of missense and synonymous variants in Iranian patients suffering from autosomal dominant polycystic kidney disease

Autosomal dominant polycystic kidney disease (ADPKD), the predominant type of inherited kidney disorder, occurs due to PKD1 and PKD2 gene mutations. ADPKD diagnosis is made primarily by kidney imaging. However, m...

Feed Item Url: 
https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-02069-0

Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases

Dipeptidyl peptidase-4 (DPP-4) is a serine protease that inhibits the degradation of glucagon-like peptide 1. DPP-4 inhibitors are used worldwide to treat type 2 diabetes mellitus and were recently shown to ha...

Feed Item Url: 
https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-02060-9

Membranous nephropathy in patients with HIV: a report of 11 cases

Membranous nephropathy (MN) has been recognized to occur in patients with human immunodeficiency virus (HIV) infection since the beginning of the HIV epidemic. The prevalence of phospholipase A2 receptor (PLA2...

Feed Item Url: 
https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-02042-x

C3-glomerulonephritis in New Zealand – a case series

C3-glomerulonephritis can lead to progressive renal impairment from complement-mediated glomerular injury. Incidence and outcomes of C3-glomerulonephritis are not known in the New Zealand population.

Feed Item Url: 
https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-02056-5